DG Capital Management LLC 13D and 13G filings for Fennec Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 12:06 pm Sale | 2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,114,692 4.100% | -407,512 (-26.77%) | Filing |
| 2024-11-12 7:38 pm Purchase | 2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,522,204 5.500% | 105,748 (+7.47%) | Filing |
| 2024-06-27 4:43 pm Purchase | 2024-05-14 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,416,456 5.200% | 1,416,456 (New Position) | Filing |